Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -18.17% is 1230% below its 5-year average of -1.37%, around the middle of its 5-year range (-41.71%–31.61%).
As of the fiscal period ended Wednesday, December 31, 2025. 45.77% below its 12-month average of -12.46%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-18.17%
RETURN ON EQUITY (ROE) AVG TTM
-12.46%
RETURN ON EQUITY (ROE) AVG 3Y
-8.76%
RETURN ON EQUITY (ROE) AVG 5Y
-1.37%
RETURN ON EQUITY (ROE) AVG 10Y
9.24%
RETURN ON EQUITY (ROE) AVG 15Y
19.12%
RETURN ON EQUITY (ROE) AVG 20Y
20.82%
CURRENT VS TTM AVG
-45.77%
CURRENT VS 3Y AVG
-107.48%
CURRENT VS 5Y AVG
-1229.51%
CURRENT VS 10Y AVG
-296.65%
CURRENT VS 15Y AVG
-195.03%
CURRENT VS 20Y AVG
-187.29%
SECTOR MEDIAN · HEALTHCARE
10.89%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-266.85%
vs the sector median at left
Baxter International Inc.
Market Cap
$11.57B
Return on Equity (ROE)
-18.17%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$11.31B
Return on Equity (ROE)
23.25%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$11.21B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.96B
Return on Equity (ROE)
10.36%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$10.91B
Return on Equity (ROE)
-6.28%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
Market Cap
$12.32B
Return on Equity (ROE)
3.35%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$10.31B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$9.75B
Return on Equity (ROE)
20.19%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baxter International Inc. (BAX) | $11.57B | -18.17% | -12.46% | -8.76% | -1.37% |
| Insulet Corp. (PODD)vs › | $11.31B | 23.25% | 25.41% | 19.99% | 14.02% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 5.25% | 5.98% | 10.62% | 11.34% |
| Align Technology, Inc. (ALGN)vs › | $11.96B | 10.36% | 10.54% | 10.84% | 19.93% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | -6.28% | -2.13% | 6.32% | 9.65% |
| Revvity, Inc. (RVTY)vs › | $12.32B | 3.35% | 3.59% | 3.35% | 7.68% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | -0.17% | 18.91% | 22.60% | 24.60% |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 20.19% | 18.80% | 15.17% | 15.31% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 12.09% | 11.88% | 12.69% | 13.50% |
ROE
-18.2%
ROA
-5.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -15.61% |
| 2024-12-31 | -9.32% |
| 2023-12-31 | 31.61% |
| 2022-12-31 | -41.71% |
| 2021-12-31 | 14.15% |
| 2020-12-31 | 12.68% |
| 2019-12-31 | 12.70% |
| 2018-12-31 | 19.71% |
| 2017-12-31 | 6.60% |
| 2016-12-31 | 59.89% |
| 2015-12-31 | 10.94% |
| 2014-12-31 | 30.75% |
| 2013-12-31 | 23.77% |
| 2012-12-31 | 33.53% |
| 2011-12-31 | 33.77% |
| 2010-12-31 | 21.62% |
| 2009-12-31 | 30.66% |
| 2008-12-31 | 32.33% |
| 2007-12-31 | 24.68% |
| 2006-12-31 | 22.26% |
| 2005-12-31 | 22.24% |
| 2004-12-31 | 10.47% |
| 2003-12-31 | 26.45% |
| 2002-12-31 | 26.23% |
| 2001-12-31 | 16.29% |
| 2000-12-31 | 27.83% |
| 1999-12-31 | 23.81% |
| 1998-12-31 | 11.10% |
| 1997-12-31 | 11.45% |
| 1996-12-31 | 26.72% |
